Stocks and Investing Stocks and Investing
Wed, May 11, 2022

Mani Foroohar Maintained (ARWR) at Hold with Decreased Target to $35 on, May 11th, 2022


Published on 2024-10-27 21:00:09 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Decreased Target from $36 to $35 on, May 11th, 2022.

Mani has made no other calls on ARWR in the last 4 months.



There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Mani's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mani


  • Madhu Kumar of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Wednesday, January 19th, 2022
Contributing Sources